An Active Self‐Mitochondria‐Targeting Cyanine Immunomodulator for Near‐Infrared II Fluorescence Imaging‐Guided Synergistic Photodynamic Immunotherapy
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202401061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Jin-Feng Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science and Engineering, Central South University, Changsha, Hunan, 410083, China. Hauptthemen laut MEDLINE: Mitochondria, Photochemotherapy, Immunotherapy, Optical Imaging. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Science and Technology of Hunan Province.
Abstract (Originalsprache)
Photodynamic therapy targeting mitochondria represents a promising therapeutic strategy for fighting diverse types of cancers. However, the currently available photosensitizers (PSs) suffer from insufficient therapeutic potency, limited mitochondria delivery efficiency, and the inability to treat invisible metastatic distal cancers. Herein, an active self‐mitochondria‐targeting heptapeptide cyanine (HCy) immunomodulator (I 2 HCy‐QAP) is reported for near‐infrared II (NIR‐II) fluorescence imaging‐guided photodynamic immunotherapy of primary and distal metastatic cancers. The I 2 HCy‐QAP is designed by introducing a quaternary ammonium salt with a phenethylamine skeleton (QAP) into the iodinated HCy photosensitizer. The I 2 HCy‐QAP can precisely target mitochondria due to the lipophilic cationic QAP unit, present strong NIR‐II fluorescence tail emission, and effectively generate singlet oxygen 1 O 2 under NIR laser irradiation, thereby inducing mitochondria‐targeted damages and eliciting strong systemic immunogenic cell death immune responses. The combination of the I 2 HCy‐QAP‐mediated photodynamic immunotherapy with anti‐programmed death‐1 antibody therapy achieves remarkable therapeutic efficacy against both primary and distal metastatic cancers with significant inhibition of lung metastasis in a triple‐negative breast cancer model. This work provides a new concept for designing high‐performance NIR emissive cyanine immunomodulators for NIR‐II fluorescence‐guided photodynamic immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Materials Science and Engineering, Central South University, Changsha, Hunan, 410083, China.
- Furong Laboratory, Central South University, Changsha, Hunan, 410008, China.
ORCID-Profile: Ming Li
Förderung
- National Natural Science Foundation of China
- Department of Science and Technology of Hunan Province
Zitieren
APA
Yu, J. F., Wen, Y., & Li, M. (2024). An Active Self‐Mitochondria‐Targeting Cyanine Immunomodulator for Near‐Infrared II Fluorescence Imaging‐Guided Synergistic Photodynamic Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401061
Vancouver
Yu JF, Wen Y, Li M. An Active Self‐Mitochondria‐Targeting Cyanine Immunomodulator for Near‐Infrared II Fluorescence Imaging‐Guided Synergistic Photodynamic Immunotherapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401061
BibTeX
@article{Yu2024,
author = {Yu, Jin-Feng and Wen, Yu and Li, Ming},
title = {An Active Self‐Mitochondria‐Targeting Cyanine Immunomodulator for Near‐Infrared II Fluorescence Imaging‐Guided Synergistic Photodynamic Immunotherapy},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202401061}
}
EUVIMED